Tag Archives: GSK LICENSES COMPANIES TO MAKE CHEAP COPIES OF HIV DRUG

British drugmaker GSK has signed deals with three companies allowing them to make inexpensive generic versions of Cabotegravir, its long-acting HIV preventive medicine, for use in lower-income countries, where the majority of new HIV cases occur. The injected drug cabotegravir was approved by regulators in the United States in late 2021. Last July, GSK announced a program with the United …

British drugmaker GSK has signed deals with three companies allowing them to make inexpensive generic versions of Cabotegravir, its long-acting HIV preventive medicine, for use in lower-income countries, where the majority of new HIV cases occur. The injected drug cabotegravir was approved by regulators in the United States in late 2021. Last July, GSK announced a program with the United …